Russell Investments Group, Ltd. Castle Biosciences Inc Transaction History

Russell Investments Group, Ltd.

$66.8 Billion
Q3 2024

A detailed history of Russell Investments Group, Ltd. transactions in Castle Biosciences Inc stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 25,374 shares of CSTL stock, worth $714,024. This represents 0.0% of its overall portfolio holdings.

Number of Shares

25,374

Previous 34,505 26.46%

Holding current value

$714,024

Previous $751,000 3.73%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$17.4 - $31.47 $158,879 - $287,352	-9,131 Reduced 26.46%	25,374 $723,000
Q2 2024 Aug 08, 2024	BUY	$18.84 - $24.94 $52,978 - $70,131	2,812 Added 8.87%	34,505 $751,000
Q1 2024 May 08, 2024	SELL	$18.06 - $25.3 $5,237 - $7,337	-290 Reduced 0.91%	31,693 $701,000
Q4 2023 Feb 05, 2024	BUY	$12.19 - $22.43 $36,545 - $67,245	2,998 Added 10.34%	31,983 $690,000
Q3 2023 Nov 13, 2023	BUY	$13.28 - $20.3 $282,399 - $431,679	21,265 Added 275.45%	28,985 $489,000
Q2 2023 Aug 10, 2023	BUY	$11.66 - $26.0 $90,015 - $200,720	7,720 New	7,720 $105,000
Q3 2022 Nov 04, 2022	BUY	$22.51 - $34.32 $1.95 Million - $2.97 Million	86,551 New	86,551 $2.26 Million
Q4 2021 Jan 21, 2022	SELL	$39.06 - $67.58 $3.47 Million - $6 Million	-88,774 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$60.13 - $77.6 $654,034 - $844,055	10,877 Added 13.96%	88,774 $5.9 Million
Q2 2021 Aug 04, 2021	SELL	$50.07 - $76.78 $105,847 - $162,312	-2,114 Reduced 2.64%	77,897 $5.71 Million
Q1 2021 May 10, 2021	SELL	$58.92 - $97.33 $1.79 Million - $2.96 Million	-30,374 Reduced 27.52%	80,011 $5.48 Million
Q4 2020 Feb 08, 2021	BUY	$43.6 - $73.05 $62,609 - $104,899	1,436 Added 1.32%	110,385 $7.41 Million
Q3 2020 Nov 09, 2020	BUY	$38.47 - $52.03 $715,349 - $967,497	18,595 Added 20.58%	108,949 $5.6 Million
Q2 2020 Aug 05, 2020	BUY	$27.28 - $43.01 $381,538 - $601,537	13,986 Added 18.31%	90,354 $3.4 Million
Q1 2020 May 06, 2020	BUY	$23.08 - $35.53 $524,954 - $808,129	22,745 Added 42.42%	76,368 $2.27 Million
Q4 2019 Jan 29, 2020	BUY	$15.74 - $35.04 $571,440 - $1.27 Million	36,305 Added 209.64%	53,623 $1.84 Million
Q3 2019 Nov 01, 2019	BUY	$18.09 - $27.92 $313,282 - $483,518	17,318 New	17,318 $313,000

Others Institutions Holding CSTL

# of Institutions

202

Shares Held

26M

Call Options Held

303K

Put Options Held

30.3K

View Full List

About CASTLE BIOSCIENCES INC

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $740M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

More about CSTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Account

Russell Investments Group, Ltd. Castle Biosciences Inc Transaction History